Mira Pharmaceuticals (MIRA) Interest Expenses (2022 - 2025)

Mira Pharmaceuticals has disclosed Interest Expenses across 4 years of filings, most recently posting $396.0 for Q4 2025.

• Interest Expenses for Q4 2025 came in at $396.0, up 101.04% year-over-year; the trailing twelve-month figure through Dec 2025 was -$8584.0 (up 93.2% YoY), and the FY2025 annual result was $13072.0, up 107.89% from the prior year.
• Interest Expenses came in at $396.0 for Q4 2025 at Mira Pharmaceuticals, down from $12441.0 in the prior quarter.
• In the past five years, Interest Expenses ranged from a high of $3.5 million in Q4 2023 to a low of -$50416.0 in Q1 2024.
• The 4-year median for Interest Expenses is $1766.0 (2022), against an average of $313354.8.
• Across the five-year window, Interest Expenses jumped 196774.8% in 2023 and sank 3149.97% in 2024, its largest moves.
• Mira Pharmaceuticals' Interest Expenses stood at $1766.0 in 2022, then surged by 196774.8% to $3.5 million in 2023, then plunged by 101.1% to -$38105.0 in 2024, then soared by 101.04% to $396.0 in 2025.
• The last three Interest Expenses figures came in at $396.0 (Q4 2025), $12441.0 (Q3 2025), and -$21421.0 (Q1 2025), per Business Quant data.